Details for Patent: 8,440,170
✉ Email this page to a colleague
Which drugs does patent 8,440,170 protect, and when does it expire?
Patent 8,440,170 protects SUPRENZA and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 8,440,170
| Title: | Orally disintegrating tablets with speckled appearance |
| Abstract: | Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients. |
| Inventor(s): | Stroppolo; Federico (Mezzovico, CH), Ardalan; Shahbaz (Mezzovico, CH) |
| Assignee: | Alpex Pharma SA (Mezzovico, CH) |
| Application Number: | 12/811,737 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,440,170 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 8,440,170
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-001 | Jun 13, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-002 | Jun 13, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Citius Pharms | SUPRENZA | phentermine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 202088-003 | Mar 27, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,440,170
| PCT Information | |||
| PCT Filed | January 30, 2009 | PCT Application Number: | PCT/EP2009/051055 |
| PCT Publication Date: | August 13, 2009 | PCT Publication Number: | WO2009/098169 |
International Family Members for US Patent 8,440,170
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2254558 | ⤷ Try a Trial | |||
| World Intellectual Property Organization (WIPO) | 2009098169 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
